These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20614802)

  • 1. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.
    Nikolaus S; Antke C; Beu M; Müller HW
    Rev Neurosci; 2010; 21(2):119-39. PubMed ID: 20614802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.
    Wong DF; Brasić JR; Singer HS; Schretlen DJ; Kuwabara H; Zhou Y; Nandi A; Maris MA; Alexander M; Ye W; Rousset O; Kumar A; Szabo Z; Gjedde A; Grace AA
    Neuropsychopharmacology; 2008 May; 33(6):1239-51. PubMed ID: 17987065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
    Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
    Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosted dopamine and blunted serotonin in Tourette syndrome - evidence from
    Nikolaus S; Mamlins E; Antke C; Dabir M; Müller HW; Giesel FL
    Rev Neurosci; 2022 Dec; 33(8):859-876. PubMed ID: 35575756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key players in major and bipolar depression--a retrospective analysis of in vivo imaging studies.
    Nikolaus S; Hautzel H; Heinzel A; Müller HW
    Behav Brain Res; 2012 Jul; 232(2):358-90. PubMed ID: 22483788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study.
    Lee LT; Tsai HC; Chi MH; Chang WH; Chen KC; Lee IH; Chen PS; Yao WJ; Chiu NT; Yang YK
    Int Clin Psychopharmacol; 2015 May; 30(3):175-8. PubMed ID: 25647452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoaminergic hypo- or hyperfunction in adolescent and adult attention-deficit hyperactivity disorder?
    Nikolaus S; Mamlins E; Giesel FL; Schmitt D; Müller HW
    Rev Neurosci; 2022 Jun; 33(4):347-364. PubMed ID: 34378877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal Modulation of Striatal Dopamine Release by Local γ-Aminobutyric Acid (GABA) Signalling.
    Roberts BM; Lopes EF; Cragg SJ
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings.
    Schneier FR; Martinez D; Abi-Dargham A; Zea-Ponce Y; Simpson HB; Liebowitz MR; Laruelle M
    Depress Anxiety; 2008; 25(1):1-7. PubMed ID: 17252580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered serotonergic and GABAergic neurotransmission in a mice model of obsessive-compulsive disorder.
    Winter C; Greene DM; Mavrogiorgou P; Schaper H; Sohr R; Bult-Ito A; Juckel G
    Behav Brain Res; 2018 Jan; 337():240-245. PubMed ID: 28916503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex.
    Jupp B; Caprioli D; Saigal N; Reverte I; Shrestha S; Cumming P; Everitt BJ; Robbins TW; Dalley JW
    Eur J Neurosci; 2013 May; 37(9):1519-28. PubMed ID: 23368520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common limbic and frontal-striatal disturbances in patients with obsessive compulsive disorder, panic disorder and hypochondriasis.
    van den Heuvel OA; Mataix-Cols D; Zwitser G; Cath DC; van der Werf YD; Groenewegen HJ; van Balkom AJ; Veltman DJ
    Psychol Med; 2011 Nov; 41(11):2399-410. PubMed ID: 21557892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice.
    Le W; Conneely OM; Zou L; He Y; Saucedo-Cardenas O; Jankovic J; Mosier DR; Appel SH
    Exp Neurol; 1999 Oct; 159(2):451-8. PubMed ID: 10506516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis.
    van den Heuvel OA; Veltman DJ; Groenewegen HJ; Witter MP; Merkelbach J; Cath DC; van Balkom AJ; van Oppen P; van Dyck R
    Arch Gen Psychiatry; 2005 Aug; 62(8):922-33. PubMed ID: 16061770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.